Agios Pharmaceuticals Inc
SWB:8AP
Agios Pharmaceuticals Inc
SWB:8AP
Price:
23.8
EUR
12.26%
Market Closed
Market Cap:
€783.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Agios Pharmaceuticals Inc
SWB:8AP
|
US |
|
Big Medya Teknoloji AS
IST:BIGTK.E
|
TR |
|
M
|
Motorola Solutions Inc
XHAM:MTLA
|
US |
|
Compagnie Generale des Etablissements Michelin SCA
F:MCHA
|
FR |
|
Universal Music Group NV
AEX:UMG
|
NL |
|
T
|
Tessenderlo Group NV
XBER:TEZ
|
BE |
|
Aena SME SA
F:A44
|
ES |
|
Wealth Minerals Ltd
XTSX:WML
|
CA |
Wall St Price Targets
8AP Price Targets Summary
Agios Pharmaceuticals Inc
Agios Pharmaceuticals Inc
Wall Street analysts forecast 8AP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 8AP is 36.55 EUR with a low forecast of 23.89 EUR and a high forecast of 57.65 EUR.
Lowest Forecast
Price Target
23.89
EUR
0% Upside
Average Forecast
Price Target
36.55
EUR
54% Upside
Highest Forecast
Price Target
57.65
EUR
142% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8AP's stock price target?
Price Target
36.55
EUR
36.55
EUR
According to Wall Street analysts, the average 1-year price target for 8AP is 36.55 EUR with a low forecast of 23.89 EUR and a high forecast of 57.65 EUR.
What is the Revenue forecast for Agios Pharmaceuticals Inc?
Projected CAGR
44%
44%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 44%.
